|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,579.60 INR | +0.51% |
|
-1.15% | +4.40% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 4.57B | - | - | |||
| 1,043B | |||||
| 621B | |||||
| 435B | |||||
| 361B | |||||
| 293B |
Select your edition
All financial news and data tailored to specific country editions
